Previous Close | 16.25 |
Open | 16.10 |
Bid | 15.60 x 800 |
Ask | 16.97 x 1000 |
Day's Range | 15.60 - 16.10 |
52 Week Range | 14.18 - 35.60 |
Volume | 16,685 |
Avg. Volume | 43,743 |
Market Cap | 363.51M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 33.25 |
Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates
Spruce Biosciences Presents Phase 1 and 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia from Endocrine Society’s 2021 Annual Mtg
Spruce Biosciences to Announce Phase 1 and 2 Data of Tildacerfont at Endocrine Society’s 2021 Annual Meeting